INMUNE BIO INC. (INMB) Return on equity 2017–2025
INMUNE BIO INC. (INMB) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-195.3%FY2025 · since FY2017: -4.6% → -195.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -195.3% | -64.2 pp |
| FY2024 | -131.1% | -50.7 pp |
| FY2023 | -80.4% | -34.9 pp |
| FY2022 | -45.4% | -7.6 pp |
| FY2021 | -37.8% | -6.6 pp |
| FY2020 | -31.2% | — |
| FY2018 | -75.2% | -70.6 pp |
| FY2017 | -4.6% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice